ISRG vs. EW, SYK, SNY, ELV, PFE, AMGN, MDT, BSX, CI, and VRTX
Should you be buying Intuitive Surgical stock or one of its competitors? The main competitors of Intuitive Surgical include Edwards Lifesciences (EW), Stryker (SYK), Sanofi (SNY), Elevance Health (ELV), Pfizer (PFE), Amgen (AMGN), Medtronic (MDT), Boston Scientific (BSX), The Cigna Group (CI), and Vertex Pharmaceuticals (VRTX). These companies are all part of the "medical" sector.
Edwards Lifesciences (NYSE:EW) and Intuitive Surgical (NASDAQ:ISRG) are both large-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, earnings, valuation, risk, community ranking, dividends, analyst recommendations, institutional ownership and media sentiment.
Edwards Lifesciences presently has a consensus target price of $92.71, suggesting a potential upside of 9.45%. Intuitive Surgical has a consensus target price of $396.17, suggesting a potential upside of 5.69%. Given Intuitive Surgical's higher possible upside, research analysts clearly believe Edwards Lifesciences is more favorable than Intuitive Surgical.
Intuitive Surgical has a net margin of 27.16% compared to Intuitive Surgical's net margin of 23.01%. Intuitive Surgical's return on equity of 22.86% beat Edwards Lifesciences' return on equity.
In the previous week, Edwards Lifesciences had 32 more articles in the media than Intuitive Surgical. MarketBeat recorded 53 mentions for Edwards Lifesciences and 21 mentions for Intuitive Surgical. Edwards Lifesciences' average media sentiment score of 0.73 beat Intuitive Surgical's score of 0.59 indicating that Intuitive Surgical is being referred to more favorably in the news media.
Intuitive Surgical has higher revenue and earnings than Edwards Lifesciences. Edwards Lifesciences is trading at a lower price-to-earnings ratio than Intuitive Surgical, indicating that it is currently the more affordable of the two stocks.
79.5% of Edwards Lifesciences shares are held by institutional investors. Comparatively, 83.6% of Intuitive Surgical shares are held by institutional investors. 1.3% of Edwards Lifesciences shares are held by company insiders. Comparatively, 0.9% of Intuitive Surgical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Edwards Lifesciences received 293 more outperform votes than Intuitive Surgical when rated by MarketBeat users. Likewise, 71.79% of users gave Edwards Lifesciences an outperform vote while only 69.05% of users gave Intuitive Surgical an outperform vote.
Edwards Lifesciences has a beta of 1.1, indicating that its stock price is 10% more volatile than the S&P 500. Comparatively, Intuitive Surgical has a beta of 1.39, indicating that its stock price is 39% more volatile than the S&P 500.
Summary
Intuitive Surgical beats Edwards Lifesciences on 11 of the 18 factors compared between the two stocks.
Get Intuitive Surgical News Delivered to You Automatically
Sign up to receive the latest news and ratings for ISRG and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding ISRG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Intuitive Surgical Competitors List
Related Companies and Tools
